|
2025
|
Invention
|
Vaccines against chlamydia sp..
The present invention describes an efficient vaccine against a C... |
|
2024
|
Invention
|
Lipid nanoparticle compositions. The present invention relates to the field of lipid nanoparticle... |
|
2023
|
Invention
|
A novel cationic adjuvant composition.
The present invention relates to an adjuvant composition ... |
|
|
Invention
|
A novel cationic adjuvant composition. The present invention relates to an adjuvant composition c... |
|
2022
|
Invention
|
Composition for preventing or treating autoimmune diseases.
The present invention relates to a c... |
|
|
Invention
|
Composition for preventing or treating autoimmune diseases. The present invention relates to a co... |
|
2021
|
Invention
|
Systems and methods for evaluating gestational progress and applications thereof.
Methods to com... |
|
|
Invention
|
Systems and methods for evaluating gestational progress and applications thereof. Methods to comp... |
|
|
Invention
|
A dna plasmid sars-corona virus-2/covid-19 vaccine.
The present invention relates to DNA vaccine... |
|
|
Invention
|
A dna plasmid sars-coronavirus-2/covid-19 vaccine. in vivo in vitro in vitro expression. The comb... |
|
|
Invention
|
Liposomal composition for preventing or early treatment of pathogenic infection.
The present inv... |
|
|
Invention
|
Liposomal composition for preventing or early treatment of pathogenic infection. The present inve... |
|
|
Invention
|
Methods for evaluation of gestational progress and preterm abortion for clinical intervention and... |
|
2020
|
Invention
|
Fusion proteins for tuberculosis vaccines. The present invention relates to fusion proteins based... |
|
|
Invention
|
Multivalent malaria transmission-blocking vaccines. The present invention relates to a method for... |
|
|
Invention
|
Multivalent malaria transmission-blocking vaccines. PfsPfsPfs48/45 to lower the required threshol... |
|
2019
|
Invention
|
Improved immunoassays. The present invention relates to improved immunoassays with the use of a h... |
|
|
G/S
|
Adjuvants, other than for medical or veterinary purposes Chemical and biological adjuvants for me... |
|
|
G/S
|
Adjuvants, other than for medical or veterinary purposes. Chemical and biological adjuvants for m... |
|
2018
|
Invention
|
A polygene influenza vaccine. The present invention relates to a nucleic acid vaccine. Specifical... |
|
|
Invention
|
Noninvasive molecular clock for fetal development predicts gestational age and preterm delivery. ... |
|
|
Invention
|
A noninvasive molecular clock for fetal development predicts gestational age and preterm delivery... |
|
|
Invention
|
Methods for producing liposomes.
The invention discloses a method for the formation of liposomes... |
|
|
Invention
|
Use of vaginal lactobacilli for improving the success rate of in vitro fertilization. in vitroLac... |
|
|
G/S
|
In vivo and in vitro diagnostic preparations, other than for medical or veterinary purposes; diag... |
|
|
G/S
|
Diagnostic reagents for in vivo and in vitro use in biochemistry, clinical chemistry and microbio... |
|
|
G/S
|
In vivo and in vitro diagnostics, other than for medical or
veterinary purposes; diagnostic reag... |
|
|
Invention
|
Chlamydia sp. Chlamydia trachomatis (Ct). The vaccine is based on recombinant fusion molecules th... |
|
2017
|
G/S
|
Vaccines; veterinary vaccines; vaccines for human use;
vaccine adjuvants. Research and developme... |
|
|
Invention
|
Adjuvants with modified drainage properties. A method of controlling the surface charge of liposo... |
|
2016
|
Invention
|
Skin testing for tuberculosis in immunocompromised persons. Mycobacterium tuberculosis antigens f... |
|
|
Invention
|
Skin testing for tuberculosis in immunocompromised persons. The present invention discloses the u... |
|
2015
|
Invention
|
Alpha-tocopherol-based adjuvanted solvent for dna vaccines. The present invention discloses a del... |
|
|
Invention
|
Vaccines comprising tb10.4. +T cells expressing high levels of IFN-γ, TNF-α, and IL-2. This in tu... |
|
|
Invention
|
M.tuberculosis vaccines. M. tuberculosis (MTB) antigens. |
|
|
Invention
|
New m.tuberculosis vaccines. The present invention is directed to a fusion protein, antigen cockt... |
|
2014
|
G/S
|
Chemicals and reagents used in science; chemicals for the manufacture of medicines and vaccines; ... |
|
|
Invention
|
Diagnostic reagents for improved in vivo or in vitro cell-mediated immunological diagnosis of tub... |
|
|
Invention
|
Tuberculosis tb vaccine to prevent reactivation. M. tuberculosis derived proteins and protein fra... |
|
|
Invention
|
Vaccines against chlamydia sp.. The present invention describes an efficient vaccine against a Ch... |
|
|
Invention
|
Pcr diagnostics of dermatophytes and other pathogenic fungi. Epidermophyton floccosum by PCR and ... |
|
|
Invention
|
A single or multistage mycobacterium avium subsp. paratuberculosis subunit vaccine. The present i... |
|
|
Invention
|
Modified cationic liposome adjuvants.
The present invention relates to the use of vaccines with ... |
|
2013
|
Invention
|
Method of diagnosing galactosemia in neonatal screening. A method of diagnosing galactosemia in b... |
|
|
Invention
|
Diagnostic pcr primers enabling exhaustive detection of non-human eukaryotic ssu rdna in human cl... |
|
|
Invention
|
M. tuberculosis vaccines. M. tuberculosis (MTB) antigens. |
|
|
Invention
|
M. tuberculosis vaccines. The present invention is directed to fusion proteins, antigen cocktails... |
|
|
Invention
|
Monoclonal antibodies. The invention covers monoclonal antibodies that can be used for i) specifi... |
|
2012
|
Invention
|
Production of a cysteine rich protein. Plasmodium falciparum. |
|
|
Invention
|
Therapeutic tb vaccine.
Therapeutic vaccines comprising polypeptides expressed during the latent... |
|
2005
|
G/S
|
Chemical products and reagents for scientific purposes;
chemical additives and agents for use in... |
|
|
G/S
|
Chemical products and reagents for scientific purposes, namely, biomedical compounds in the form ... |
|
2002
|
G/S
|
Information and counselling concerning diseases and illnesses, disease and illness prevention and... |
